Cure Pharmaceutical Holding Corp. Contracts & Agreements

Form of Note dated as of June 28, 2024, issued by the Company to the investor (Filed With SEC on July 5, 2024)

Securities Purchase Agreement dated as of June 28, 2024, by and between the Company and the investor (Filed With SEC on July 5, 2024)

Distribution Services Agreement, dated April 1, 2022, by and between The Sera Labs, Inc. and Advanced Legacy Technologies LLC (Filed With SEC on May 17, 2024)

Senior Secured Promissory and Security Agreement dated as of January 4, 2024, by and between the Company and the Executive (Filed With SEC on January 12, 2024)

Employment Agreement dated as of January 1, 2023, by and between Avenir Wellness Solutions, Inc. and Nancy Duitch (Filed With SEC on March 8, 2023)

Employment Agreement, dated July 22, 2022, by and between the Company and Joel Bennett (Filed With SEC on July 28, 2022)

Trademark License Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer (Filed With SEC on July 28, 2022)

Transition Services Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer (Filed With SEC on July 28, 2022)

Guaranty, dated July 22, 2022, by and between the Company and Buyer (Filed With SEC on July 28, 2022)

Side Letter, dated July 22, 2022, by and between the Company and Buyer (Filed With SEC on July 28, 2022)

Promissory Note, dated July 22, 2022, issued by Buyer for the benefit of CURE Pharmaceutical (Filed With SEC on July 28, 2022)

Asset Purchase Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer (Filed With SEC on July 28, 2022)

Forbearance Agreement (Filed With SEC on January 7, 2022)

Consent and Waiver Agreement, dated February 25, 2021, by and between the Company and Ionic Ventures, LLC (Filed With SEC on February 25, 2021)

Security Purchase Agreement (Filed With SEC on November 2, 2020)

Series A Convertible Note (Filed With SEC on November 2, 2020)

Series B Convertible Note (Filed With SEC on November 2, 2020)

Note Purchase Agreement (Filed With SEC on November 2, 2020)

Secured Promissory Note (Filed With SEC on November 2, 2020)

Master Netting Agreement (Filed With SEC on November 2, 2020)

Registration Rights Agreement (Filed With SEC on November 2, 2020)

Leak-Out Agreement (Filed With SEC on November 2, 2020)

Agreement and Plan of Merger, dated September 23, 2020, by and between CURE Pharmaceutical Holding Corp. (the Company), The Sera Labs, Inc. and the other parties thereto (Filed With SEC on October 5, 2020)

Form of Lock-Up Agreement (Filed With SEC on October 5, 2020)

Employment Agreement, dated October 2, 2020, by and between the Company and Nancy Duitch (Filed With SEC on October 5, 2020)

Secured Promissory Note, dated September 25, 2020, by and between CURE Pharmaceutical Holding Corp. and Ionic Ventures, LLC (Filed With SEC on September 30, 2020)

Separation Agreement, dated May 8, 2020, by and between the Company and Jessica Rousset (Filed With SEC on August 14, 2020)

Secured Promissory Note (Filed With SEC on July 28, 2020)

Release, Waiver and Amendment (Filed With SEC on June 9, 2020)

Amendment to Warrants to Purchase Common Stock (Filed With SEC on June 9, 2020)

Specimen common stock certificate (Filed With SEC on March 30, 2020)

Description of Registrants Securities (Filed With SEC on March 30, 2020)

Amended and Restated Cure Pharmaceutical Holding Corp. 2017 Equity Incentive Plan (Filed With SEC on March 30, 2020)

Form of Stock Option Agreement for the Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on March 30, 2020)

Form of Restricted Stock Unit Agreement for the Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on March 30, 2020)

Form of Restricted Stock Award Agreement for the Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on March 30, 2020)

Merger Agreement, dated March 31, 2019 (Filed With SEC on December 31, 2019)

Convertible Promissory Note dated November 12, 2019 (Filed With SEC on November 14, 2019)

Plan of Conversion, dated September 27, 2019 (Filed With SEC on October 4, 2019)

Employment Agreement (Filed With SEC on May 20, 2019)

Convertible Demand Note Issued by Cure Pharmaceutical Holding Corp. to Chemistry Holdings, Inc (Filed With SEC on April 1, 2019)

Advisory Consulting Agreement with Michael J. Willner dated December 14, 2018 (Filed With SEC on January 7, 2019)

Securities Purchase Agreement dated December 14, 2018 (Filed With SEC on January 7, 2019)

Employment Agreement dated March 15 , 201 7 with Jessica Rousset (Filed With SEC on November 30, 2018)

Employment Agreement dated November 15, 2018 with Alex Katz (Filed With SEC on November 20, 2018)

Form of Securities Purchase Agreement, by and between the Company and the Investors, with the form of Note (Filed With SEC on October 18, 2018)

Form of Securities Purchase Agreement between CURE Pharmaceutical Holding Corp. and various investors for up to $5,000 in convertible promissory notes, dated March 20, 2018 (Filed With SEC on March 26, 2018)

Form of 9% Convertible Promissory Note, dated March 20, 2018 (Filed With SEC on March 26, 2018)

Form of Warrant, dated March 20, 2018 (Filed With SEC on March 26, 2018)

Form of Warrant, dated December 6, 2016 (Filed With SEC on December 14, 2016)

Share Exchange and Conversion Agreement, dated November 7, 2016 (Filed With SEC on November 15, 2016)

Form of Share Cancellation Agreement, dated November 7, 2016 (Filed With SEC on November 15, 2016)

Form of Warrant, dated November 7, 2016 (Filed With SEC on November 15, 2016)

AGREEMENT FOR SALE OF ASSETS (Filed With SEC on August 26, 2016)

VERBAL AGREEMENT (Filed With SEC on August 19, 2015)

LOAN AGREEMENT (Filed With SEC on June 10, 2015)

LEASE AGREEMENT (Filed With SEC on June 10, 2015)

Agreement for Sale of Goods (Filed With SEC on June 10, 2015)

Category

Industry

Companies

Contracts

Cure Pharmaceutical Holding Corp. Contracts & Agreements